These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23160259)

  • 1. Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients.
    Holme I; Fellström BC; Jardine AG; Hartmann A; Holdaas H
    Clin J Am Soc Nephrol; 2013 Feb; 8(2):241-7. PubMed ID: 23160259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for graft loss and death among kidney transplant recipients: A competing risk analysis.
    Pinto-Ramirez J; Garcia-Lopez A; Salcedo-Herrera S; Patino-Jaramillo N; Garcia-Lopez J; Barbosa-Salinas J; Riveros-Enriquez S; Hernandez-Herrera G; Giron-Luque F
    PLoS One; 2022; 17(7):e0269990. PubMed ID: 35834500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Staffler B; Pedersen TR;
    Transplantation; 2005 Jan; 79(2):205-12. PubMed ID: 15665769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
    Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
    Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher immunoglobulin A nephropathy recurrence in related-donor kidney transplants: The Japan Academic Consortium of Kidney Transplantation study.
    Okumi M; Okada D; Unagami K; Kakuta Y; Iizuka J; Takagi T; Shirakawa H; Omoto K; Ishida H; Tanabe K;
    Int J Urol; 2019 Sep; 26(9):903-909. PubMed ID: 31328329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial.
    Fellström B; Holdaas H; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Logan JO; Pedersen TR;
    Kidney Int; 2004 Oct; 66(4):1549-55. PubMed ID: 15458450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial.
    Weiner DE; Park M; Tighiouart H; Joseph AA; Carpenter MA; Goyal N; House AA; Hsu CY; Ix JH; Jacques PF; Kew CE; Kim SJ; Kusek JW; Pesavento TE; Pfeffer MA; Smith SR; Weir MR; Levey AS; Bostom AG
    Am J Kidney Dis; 2019 Jan; 73(1):51-61. PubMed ID: 30037726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New scoring system identifies kidney outcome with radiation therapy in acute renal allograft rejection.
    Chen LM; Godinez J; Thisted RA; Woodle ES; Thistlewaite JR; Powers C; Haraf D
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):999-1003. PubMed ID: 10705023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
    Drechsler C; Pihlstrøm H; Meinitzer A; Pilz S; Tomaschitz A; Abedini S; Fellstrom B; Jardine AG; Wanner C; März W; Holdaas H
    Transplantation; 2015 Jul; 99(7):1470-6. PubMed ID: 25675199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-identical sibling renal transplantation--a 21-yr single-center experience.
    de Mattos AM; Bennett WM; Barry JM; Norman DJ
    Clin Transplant; 1999 Apr; 13(2):158-67. PubMed ID: 10202612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis.
    Fonseca I; Teixeira L; Malheiro J; Martins LS; Dias L; Castro Henriques A; Mendonça D
    Transpl Int; 2015 Jun; 28(6):738-50. PubMed ID: 25689397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
    Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
    Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cause, timing, kidney function recovery, and recurrent events on the prognosis of acute kidney injury in kidney transplant recipients.
    van Dijk TY; Rahamimov R; Chagnac A; van Dijk DJ; Mor E; Shlomai A; Rozen-Zvi B
    Clin Transplant; 2018 Oct; 32(10):e13398. PubMed ID: 30175412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes after Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis.
    Clayton PA; McDonald SP; Russ GR; Chadban SJ
    J Am Soc Nephrol; 2019 Sep; 30(9):1697-1707. PubMed ID: 31308074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.
    Sharif A; Alachkar N; Bagnasco S; Geetha D; Gupta G; Womer K; Arend L; Racusen L; Montgomery R; Kraus E
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1320-7. PubMed ID: 22626962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?
    Halleck F; Khadzhynov D; Liefeldt L; Schrezenmeier E; Lehner L; Duerr M; Schmidt D; Bamoulid J; Lachmann N; Waiser J; Budde K; Staeck O
    Nephrol Dial Transplant; 2016 Dec; 31(12):2143-2149. PubMed ID: 27369852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing Risk Analysis in Renal Allograft Survival: A New Perspective to an Old Problem.
    El Ters M; Smith BH; Cosio FG; Kremers WK
    Transplantation; 2021 Mar; 105(3):668-676. PubMed ID: 32332421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients.
    Lim WH; Chadban SJ; Clayton P; Budgeon CA; Murray K; Campbell SB; Cohney S; Russ GR; McDonald SP
    Clin Transplant; 2012; 26(4):E428-37. PubMed ID: 22672477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of selected factors on long-term kidney graft survival--a multivariable analysis.
    Zukowski M; Kotfis K; Kaczmarczyk M; Biernawska J; Szydłowski L; Zukowska A; Sulikowski T; Sierocka A; Bohatyrewicz R
    Transplant Proc; 2014 Oct; 46(8):2696-8. PubMed ID: 25380897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.